Johnson & Johnson (JNJ) earnings · P/E 17, rev $94.19B
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
This JNJ earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported JNJ revenue for 2025-12-28 was $94.19B. Net income was $26.80B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
When the next JNJ 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for JNJ. We will not invent a beat or miss.
Not investment advice. Full JNJ research stays on the stock page; the tape stays on the quote page.
Not investment advice.